Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026
Go back to Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 34.81 +2.44 (7.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.37 | 52 Week High | $5.17 | |||
| Open | $31.76 | 52 Week Low | $0.94 | |||
| Day High | $35.90 | P/E | N/A | |||
| Day Low | $31.76 | EPS | $0.00 | |||
| Volume | 6,216,753 | |||||
